HRA003260
Title:
Shanghai General Hospital Osteosarcoma Cohort
Release date:
2022-11-03
Description:
Osteosarcoma (OS) is the primary malignant bone tumor that most commonly affects children, adolescents, and young adults. Here we present the first large cohort of 121 OS patients from Shanghai General Hospital (SGH-OS Cohort), using hybrid-capture DNA sequencing, array-based DNA copy number, DNA methylation profiling and mRNA sequencing. Through integrating multi-omics data, we obtained a comprehensive genomic, epigenomic and transcriptomic landscape of OS and uncovered four distinct molecular subtypes with varied oncogenic factors. Moreover, we explored the diversity of clinical outcomes and the subtype-based targeted intervention that may influence OS clinical management. Our study provides a valuable insight into the biology of this disease, and a strong foundation of future precision medicine for each subtype that will eventually improve overall survival of osteosarcoma.
Data Accessibility:   
Controlled access Request Data
BioProject:
Study type:
Disease Study
Disease name:
osteosarcoma
Data Access Committee

For each controlled access study, there is a corresponding Data Access Committee(DAC) to determine the access permissions. Access to actual data files is not managed by NGDC.


DAC NO.:
DAC name:
SGH-OS-DAC
Contact person:
Hua Yingqi
Email:
yhua@shsmu.edu.cn
Description:
DAC of Shanghai General Hospital, Shanghai bone tumor institute.
Individuals & samples
Submitter:   Hua Yingqi / yhua@shsmu.edu.cn
Organization:   Shanghai bone tumor Institute, Shanghai General hospital, Shanghai Jiaotong University School of Medicine
Submission date:   2022-10-16
Requests:   23